HPLC Purity vs. Peptide Content: What the Numbers Mean

A peptide Certificate of Analysis might report:

HPLC purity: 98.7%
Peptide content: 76.4%
Water: 6.2%
Counterion: 15.8%

At first glance, these values may seem contradictory. How can a material be almost 99% pure while containing only about 76% peptide?

The answer is that HPLC purity and peptide content measure different characteristics.

What does HPLC purity mean?

Reversed-phase HPLC separates sample components according to their interactions with a chromatographic column and mobile phase. A detector records the separated components as peaks, and purity is often reported using a peak-area calculation:

Area of the principal peptide peak / total integrated peak area x 100

If the main peak accounts for 98% of the integrated signal, the reported chromatographic purity may be approximately 98%.

HPLC is a powerful method for detecting and separating peptide-related impurities, but the result applies only to the components detected, separated, and integrated under the specified method. Peptide HPLC performance depends on the column, mobile phase, gradient, wavelength, sample preparation, and other method conditions.[1]

Area percent is not total vial mass percent

An HPLC detector does not ordinarily place every component of the dried material onto a complete mass balance. Some components may:

Produce little or no signal at the selected wavelength
Elute near the solvent front
Be excluded from integration
Remain unresolved from another peak
Not be retained by the column
Be lost or changed during sample preparation

Water, chloride, acetate, trifluoroacetate, residual solvents, and many common excipients do not necessarily contribute to a peptide UV chromatogram in proportion to their physical mass. A material can therefore produce one dominant peptide peak while still containing a substantial amount of non-peptide mass.

What is peptide content?

Peptide content - sometimes called net peptide content, peptide assay, or simply content - describes how much of the weighed material consists of peptide rather than water, counterions, solvents, and other non-peptide components. The exact meaning depends on the test method and reporting basis.

Peptide content may be evaluated using:

Quantitative amino-acid analysis
A validated HPLC assay against a characterized reference standard
Quantitative nuclear magnetic resonance
UV spectrophotometry for suitable sequences
Nitrogen or elemental analysis in limited contexts
A combination of orthogonal methods

A publication on synthetic-peptide reference standards describes amino-acid analysis among the methods used to establish peptide composition and content, and emphasizes using multiple analytical procedures when assigning reference-standard values.[2]

What is amino-acid analysis?

In quantitative amino-acid analysis, the peptide is hydrolyzed into its constituent amino acids. The released amino acids are separated and quantified, and the measured amounts are compared with the known sequence to estimate the amount of peptide present in the original sample. The method can also help verify whether the relative amino-acid composition is consistent with the proposed sequence.

Amino-acid analysis has important limitations:

Some amino acids can degrade during hydrolysis.
Tryptophan may require a specialized procedure.
Cysteine may require oxidation or separate handling.
Asparagine is typically converted to aspartic acid.
Glutamine is typically converted to glutamic acid.
Incomplete hydrolysis can affect recovery.
Free amino acids or amino-acid-containing impurities may affect results.

The procedure must therefore be appropriately designed, calibrated, and interpreted.

What non-peptide components reduce net peptide content?

Counterions

Positively charged peptide sites may be associated with acetate, trifluoroacetate, chloride, or another counterion. These ions add physical mass but are not part of the covalent peptide sequence. A highly cationic peptide can associate with several counterions, making their contribution substantial. Counterions can be quantified separately using methods such as ion chromatography.[3] Our article on peptide salts and counterions covers this in depth.

Water

Lyophilized materials usually contain some residual water and may absorb additional moisture during handling. Water contributes to the measured weight but does not create a peptide peak in ordinary reversed-phase HPLC. Its amount may be evaluated by Karl Fischer titration or another suitable moisture method. See what lyophilized means for the drying process behind this.

Residual solvents

Solvents used during synthesis, purification, isolation, or lyophilization may remain at low levels - for example acetonitrile, methanol, ethanol, dimethylformamide, or dimethyl sulfoxide. Residual-solvent testing commonly uses gas chromatography or another compound-appropriate method.

Residual acids and salts

Excess trifluoroacetic acid, acetic acid, inorganic salts, buffer components, or exchange reagents may contribute additional mass.

Formulation components

A prepared research material may intentionally contain buffers, sugars, bulking agents, stabilizing agents, surfactants, or other excipients. These components are distinct from peptide-related impurities and must be accounted for when interpreting total mass.

What are peptide-related impurities?

Peptide-related impurities are molecules structurally related to the intended sequence. Examples include:

Truncated sequences
Deletion sequences
Insertion sequences
Oxidized forms
Deamidated forms
Isomerized residues
Epimerized residues
Incorrectly formed disulfide variants
Incompletely deprotected products
Aggregates or covalent multimers

FDA guidance emphasizes that synthetic-peptide impurities may be structurally similar to the intended peptide and may require sensitive, orthogonal analytical procedures for detection and characterization.[4] These impurities may contribute to the HPLC peak-area calculation because many absorb at similar wavelengths to the target peptide.

A hypothetical example

Suppose a vial contains 100 mg of lyophilized material. Independent testing reports net peptide content of 80% and HPLC principal-peak purity of 95%.

The 80% content result suggests that approximately 80 mg of the total material is peptide-derived mass, while approximately 20 mg consists of counterions, water, solvents, or other non-peptide components.

If the 95% HPLC value could be treated as a reasonable approximation of the proportion of peptide-derived material represented by the intended principal component, a simplified estimate would be:

100 mg x 0.80 x 0.95 = 76 mg

Under those simplifying assumptions, the vial would contain approximately 76 mg of the principal peptide sequence. This is an educational approximation, not a universal analytical formula. HPLC detector responses may differ between components, coelution may occur, and area percentage does not always equal mass percentage.

Can a peptide be 100% pure by HPLC but have low content?

Conceptually, yes. Imagine a material containing one peptide species, a large amount of counterion, and residual water.

The peptide portion might produce only one detectable chromatographic peak, leading to a value close to 100% area purity. The total solid, however, might contain substantially less than 100% peptide by mass because water and counterions contribute to the gross weight.

This is not inherently evidence that the chromatographic result is false. It means the chromatogram and the content assay answer different questions.

Can content be high while HPLC purity is lower?

Yes. A sample may contain a high overall proportion of peptide-derived material but include several related peptide species. For example, the sample might contain 97% total peptide material, of which 90% is the intended full-length sequence, 7% is truncated or modified peptide impurities, and the remaining 3% is water and counterions.

The net peptide content would be high because both target and related impurities are peptide-derived. The principal-peak HPLC purity would be lower because the method separates the target from other peptide species.

Does HPLC purity confirm identity?

No. A large peak shows that one detected component dominates the chromatogram under the stated conditions. It does not independently establish that the component is the intended sequence. Identity may be evaluated using intact-mass spectrometry, tandem mass spectrometry, amino-acid analysis, peptide mapping, nuclear magnetic resonance, comparison with a qualified reference standard, or other structure-appropriate methods.

ICH Q6A treats identification, assay, and impurities as distinct universal tests rather than interchangeable results.[5] Our article on peptide purity and identity works through that separation.

Why detection wavelength matters

Peptides are frequently monitored at low ultraviolet wavelengths where the peptide backbone absorbs. However, different peptides and impurities may not produce identical detector responses per unit mass. Aromatic residues such as tryptophan and tyrosine can contribute strongly at certain wavelengths, while other compounds may absorb weakly.

A peak-area percentage is therefore best understood as a relative detector-response percentage under a defined method, not a universal gravimetric measurement. Method specificity matters. If two components coelute, the chromatogram may count them as one peak. If an impurity does not absorb sufficiently at the selected wavelength, it may be underrepresented.

Why "HPLC tested" is not enough

A meaningful chromatographic report should identify:

Column type and dimensions
Mobile phases
Gradient program
Flow rate
Column temperature
Detection wavelength
Sample concentration
Injection volume
Integration method
Principal-peak retention time
System-suitability criteria
Whether mass-spectrometric detection was also used

The phrase "HPLC tested" provides little information about whether the method could separate the target peptide from important related impurities.

How should a certificate of analysis present these results?

Ideally, a CoA should list separate fields for:

Identity: the method used to confirm the proposed molecular structure
Chromatographic purity: the main-peak area percentage and analytical method
Peptide content or assay: the amount of peptide present on a clearly stated basis
Water: reported using an appropriate moisture method
Counterion: type and measured quantity
Residual solvents: individual compounds and results, when tested
Appearance: a descriptive physical observation, not a substitute for analytical results
Lot number and dates: connecting the data to a specific production batch

Useful questions when comparing peptide reports

Is the purity number based on HPLC area percentage or a quantitative assay?
At what wavelength was the chromatogram recorded?
Were all relevant peaks integrated?
Was identity confirmed separately?
Was peptide content measured?
Were water and counterions quantified?
Is the result reported as-is or on a dry basis?
Was the exact supplied lot tested?
Is the full chromatogram available?
Were orthogonal methods used to investigate unresolved impurities?

Key takeaway

HPLC purity and peptide content are independent measurements.

HPLC purity describes the relative chromatographic signal of the principal component compared with other detected peaks under a defined method. Peptide content estimates how much of the total weighed material consists of peptide rather than water, counterions, solvents, and other non-peptide components.

A scientifically useful Certificate of Analysis reports both values clearly and does not imply that a single percentage completely defines the composition or identity of a peptide material.

References

Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol 2007;386:3-55. PMC7119934.
McCarthy D, Han Y, Carrick K, et al. Reference standards to support quality of synthetic peptide therapeutics. Pharm Res 2023;40:1317-1328. PMC10338602.
Mrozik W, Markowska A, Guzik L, Kraska B, Kamysz W. Determination of counter-ions in synthetic peptides by ion chromatography, capillary isotachophoresis and capillary electrophoresis. J Pept Sci 2012;18(3):192-198. PMID: 22252914.
FDA: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin (Guidance for Industry, CDER, 2021).
ICH Q6A: Specifications - Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products (FDA, 2000).

HPLC Purity vs. Peptide Content: Why the Percentages Can Be Different